SIM
LGND icon

Spark Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Spark Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,855
Closed -$356K – 180
2020
Q1 		$356K Sell
7,855
-28,854
-79% -$1.64M 0.19% 169
2019
Q4 		$2.39M Hold
36,709
– – 0.28% 110
2019
Q3 		$2.28M Hold
36,709
– – 0.29% 109
2019
Q2 		$2.61M Buy
+36,709
New +$2.7M 0.18% 170
2013
Q4 		– Sell
-53,059
Closed -$1.43M – 678
2013
Q3 		$1.43M Buy
+53,059
New +$1.49M 0.33% 84

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Spark Investment Management's LGND Position: Q2 2020 in Review

Spark Investment Management sold out of Ligand Pharmaceuticals (LGND) in Q2 2020, closing a stake of 7,855 shares — an estimated $356K sold.

Spark Investment Management first reported a position in LGND in Q3 2013 and held it in 5 quarters. The position peaked at $2.61M in Q2 2019. 262 funds tracked by Wall St. Rank hold LGND as of Q2 2020.

  • Spark Investment Management reported no remaining Ligand Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 7,855 Ligand Pharmaceuticals shares in Q2 2020, an estimated $356K.
  • Spark Investment Management first reported a position in Ligand Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Spark Investment Management's Ligand Pharmaceuticals position peaked at $2.61M in Q2 2019.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.